Watch as Dr. Dubinsky discusses the limitations of traditional treatment for inflammatory bowel disease (IBD) and the potential advantages of biologics, which offer personalized treatment and a focus on prevention.
Related Presenters
Professor of Pediatrics and Medicine (Gastroenterology)
Chief, Division of Pediatric Gastroenterology at Mount Sinai Kravis Children’s Hospital
Co-Director, Susan and Leonard Feinstein Clinical IBD Center
Related Videos
